CD44 expression suppressed ferroptosis in cancer cells and might exert its function as a glioma promoter by increasing tumor cell invasion and proliferation, which therefore could be a promising therapeutic target (Mooney et al., 2016; Liu et al., 2019). Here, CD44 is linked to neoplasm.